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The effector proteins IpaJ and VirA, from the bacterium Shigella flexneri, block the general secretory pathway
(GSP) at different stages. In this issue of Cell Host & Microbe, Dobbs et al. (2015) use these proteins as a tool
to pinpoint STING trafficking and signaling to the ER-Golgi intermediate compartment (ERGIC).The recognition of microbes relies on the
presence of germline-encoded pattern
recognition receptors (PRRs) that sense
pathogen-associated molecular patterns
(PAMPs) in various compartments. A
common feature of microbial infection is
the release of nucleic acids into the
cytosol of the infected cell; these are typi-
cally derived from the microbial genome
itself, or its respective replication or
transcription intermediates. While the
detection of microbial RNAs has been
characterized in great detail, the mecha-
nisms for cytoplasmic DNA detection
remained elusive until the recent discov-
ery of the nucleotidyltransferase cGAS
(cyclic GMP-AMP synthase). Upon DNA
recognition, cGAS generates a second
messenger molecule, cyclic GMP-AMP
(cGAMP), which in turn activates the ER-
resident adaptor protein STING (Cai
et al., 2014). Activated STING subse-
quently translocates from the ER toward
the Golgi compartment to recruit TBK1
and the transcription factor IRF3, resulting
in antiviral gene expression (Barber, 2014;
Cai et al., 2014). However, the exact
spatiotemporal trafficking of STING, in
relation to its signaling activity, remains
unclear.
In this issue of Cell Host & Microbe,
Dobbs et al. (2015) shed light on the rela-
tionship between STING trafficking and
activation by studying the mechanisms
of cytoplasmic Shigella detection (Fig-
ure 1). Shigella flexneri is a Gram-nega-
tive, non-flagellated bacterium that
causes bacillary dysentery in humans.
Shigella infection is facilitated by effector
proteins secreted via its type III secretion
system into the cytoplasm of the host
cell. Among other perturbations, invasive
Shigella cause a dramatic fragmentation
of the host cell Golgi apparatus, a function
that is non-redundantly ascribable to two
effector proteins, IpaJ and VirA (Burnaev-skiy et al., 2013). Previous reports have
shown that IpaJ and VirA efficiently block
vesicular transport through the general
secretory pathway (GSP) by interfering
with ARF1 and Rab1, respectively (Bur-
naevskiy et al., 2013; Dong et al., 2012;
Selyunin et al., 2014). IpaJ is a cysteine
protease that cleaves the myristoyl-group
at the N-terminal glycine of the ARF1
GTPase, while VirA functions as a
GTPase-activating protein that hydro-
lyzes GTP to block Rab1 signaling (Bur-
naevskiy et al., 2013; Dong et al., 2012).
As characterized in detail for the VirA ho-
molog EspG, this inhibition does not
disrupt cargo exit at the ER, but rather
prevents cargo transport beyond the
ER-Golgi intermediate compartments
(ERGIC) (Selyunin et al., 2014). The ERGIC
localizes between the ER-exit sites and
the Golgi where it bridges the long dis-
tance between the ER and the Golgi in
cells of higher eukaryotes. The ERGIC is
believed to sort ER-derived COPII vesi-
cles for anterograde transport to the Golgi
or retrograde transport to the ER (Bran-
dizzi and Barlowe, 2013).
Detection of Shigella infection is known
to involve both TLR4 and the NLRC4 in-
flammasome; however, a role for cyto-
solic-nucleic-acid sensing pathways has
not yet been described. To address this
question, Dobbs et al. (2015) infected mu-
rine embryonic fibroblasts with wild-type
Shigella or mutants that were deficient
for the effector proteins IpaJ (Shigella
DipaJ) or VirA (Shigella DvirA) or a mutant
strain unable to invade the cytoplasm
(DmxiD). While pro-inflammatory gene
expression was comparable for all these
strains studied, host cell invasionwas crit-
ically required to elicit type I interferon
(IFN) gene expression. Moreover, while
both wild-type andDvirA Shigella induced
only modest type I IFN expression,
Shigella DipaJ as well as the doubleCell Host & Microbe 18mutant displayed a strong increase. Sub-
sequent experiments showed that this
response was fully dependent on the
cGAS-STING axis, thereby suggesting
that IpaJ specifically interfered with this
signaling cascade. To address this,
Dobbs et al. (2015) went on to investigate
whether the previously reported IpaJ-
mediated GSP block also impaired STING
trafficking. Mouse embryonic fibroblasts
expressing GFP-tagged STING were mi-
croinjected with ‘‘naked DNA’’ in the pres-
ence of recombinant IpaJ or VirA; IpaJ
arrested STING at the ER membrane,
while VirA allowed STING to exit the ER
membrane but blocked its trafficking
beyond the ERGIC. Accordingly, STING
largely remained at the ER in cells infected
withwild-typeShigella, but readily translo-
cated to the ERGIC and in part also to the
Golgi upon infection with IpaJ-deficient
Shigella. Consistent with the notion that
STING signaling emanates from the
ERGIC, TBK1 co-localized to the ERGIC
in the context of Shigella DipaJ infection.
Corroborating this model, Listeria mono-
cytogenes (another intracellular pathogen)
engineered to express Shigella IpaJ, dis-
played strongly reduced TBK1 activation
and type I IFN gene expression compared
to wild-type or virA-transgenic Listeria.
Consistent with its pivotal role in
orchestrating anti-microbial immune de-
fenses, excessive STING signaling medi-
ated by the presence of endogenous
DNA species, or by gain-of-function mu-
tations within STING itself, has been
associated with severe sterile inflamma-
tory conditions (Liu et al., 2014). Dobbs
et al. (2015) observed that disease-asso-
ciated STING mutants trafficked to the
ERGIC and Golgi in the absence of addi-
tional cGAMP recognition. This sponta-
neous trafficking to the ERGIC resulted
in the recruitment of TBK1 and type I IFN
production; whereas adding IpaJ to the, August 12, 2015 ª2015 Elsevier Inc. 137
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Figure 1. STING Signaling at the ERGIC
Upon binding of DNA, the cytoplasmic nucleotidyltransferase cGAS synthesizes the second messenger
cGAMP that subsequently activates the ER-resident adaptor molecule STING. Activated STING dissoci-
ates from the ER exit sites (ERES) and traffics to the ER-Golgi intermediate compartment (ERGIC) where
it recruits TBK1 and IRF3 to trigger type I IFN expression. The Shigella effector protein IpaJ efficiently
blocks type I IFN induction by inhibiting STING trafficking from the ER to the ERGIC by de-myristoylating
the ARF1 GTPase (Brefeldin A treatment results in a similar block). After signaling from the ERGIC, STING
immediately, or after trafficking through the Golgi, localizes to perinuclear punctate structures that may be
associated with STING degradation, possibly involving autophagy. The Shigella effector protein VirA
blocks STING trafficking from the ERGIC to theGolgi by hydrolyzing the Rab1GTP toRab1GDP.However,
this block in STING trafficking does not alter type I IFN levels, indicating that the induction of type I IFN
expression occurs already at the ERGIC. A similar effect is achieved by the microtubule inhibitor nocoda-
zole. In contrast to wild-type STING, disease-associated STING mutants (labeled with an asterisk) trans-
locate from the ER to the ERGIC in a ligand-independentmanner. Constant trafficking to the ERGIC and the
increased longevity of STING causes chronic type I IFN expression that is associated with inflammation.
The fact that disease-associated STING mutants do not localize to perinuclear punctate structures might
support the notion that ligand binding-induced degradation might take place in these punctate structures.
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cascade. Remarkably, these constitu-
tively active STINGmutants were not sub-
jected to degradation, as was readily
observed for wild-type STING when acti-
vated in the context of naked DNA deliv-
ery. These data indicated that constitutive
type I IFN signaling in patients with such
STING mutations is caused by ligand-in-
dependent STING trafficking to the
ERGIC and the failure to terminate STING
signaling by the induction of STING
degradation.
Thus, by employing the Shigella
effector proteins IpaJ and VirA as tools,
Dobbs et al. (2015) could elegantly
pinpoint ligand-dependent and -indepen-
dent STING trafficking and associated in-
duction of type I IFN signaling to the
ERGIC. Until recently, activated STING
was described to dissociate from the ER138 Cell Host & Microbe 18, August 12, 2015and to translocate through the Golgi to
perinuclear punctate structures, where it
would recruit TBK1 and initiate signal
transduction (Barber, 2014). However,
the exact nature and function of these
STING punctate structures has remained
controversial. To this end, while auto-
phagy-related components have been
shown to co-localize with these STING-
positive vesicles, the double-membrane
morphology associated with classical
autophagy has not been documented. In
addition, genetic studies have not pro-
vided a concordant picture on the role of
autophagy in STING signaling (Burdette
and Vance, 2013). The data presented
here now demonstrate that IRF3 activa-
tion and subsequent type I IFN induction
can already take place at the ERGIC, at
least in the course of Shigella DipaJ infec-
tion. Nevertheless, it is interesting to noteª2015 Elsevier Inc.that Dobbs et al. (2015) did not observe
STING at the ERGIC in cells that were
stimulated with naked DNA. In fact,
DNA-stimulated cells displayed STING
at vesicular compartments that were
negative for ER, ERGIC and Golgi
markers, similar to the punctate struc-
tures illustrated by previous reports
(Barber, 2014). Although this could be in-
terpreted as ERGIC-independent STING
signaling, these findings could also be ex-
plained by the faster kinetics of naked-
DNA-triggered STING trafficking through
the ERGIC in the timeframe studied. In
this context it is also important to keep
in mind that the STING/ERGIC co-locali-
zation studies were done in Shigella-in-
fected cells, in which ERGIC to Golgi
transport was disrupted by the presence
of VirA, trapping STING within the ERGIC.
Of note, blocking ERGIC to Golgi trans-
port using the microtubule inhibitor noco-
dazole did not interfere with STING
signaling induced by naked DNA. Conse-
quently, assuming that these punctate
structures originate from the ERGIC or
Golgi, these data indirectly suggest that
STING signal transduction triggered by
naked DNA is also initiated from the
ERGIC. However, more direct evidence
will be required to clarify this point. In
this context it would be interesting to
study STING localization within the
ERGIC at earlier time points after DNA
transfection, and to study STING traf-
ficking upon infection with pathogens
that do not interfere with the GSP. On
the other hand, regarding the unique role
of these punctate structures in the
context of STING signaling, it is tempting
to speculate that their appearance is
functionally linked to the degradation of
STING. Indeed, DNA transfection has
been shown to rapidly terminate STING
signaling by a process that involves the
phosphorylation and subsequent degra-
dation of STING (Konno et al., 2013).
Degradation of STING was also seen by
Dobbs et al. (2015) when transfecting
naked DNA, yet not in the context of
Shigella DipaJ infection. These findings
suggest that STING degradation is linked
to its transport beyond the ERGIC and/or
that VirA interferes with STING degrada-
tion directly.
Finally,Dobbsandcolleaguesalso show
that disease-associated, gain-of-function
STINGmutants,whichsignal ina ligand-in-
dependent manner, spontaneously traffic
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abated type I IFN expression. The reason
for this constitutive STING translocation
to the ERGIC remains unclear; however,
as the authors suggest, it is possible that
these mutations disrupt the interaction of
STINGwith anER-resident retentionsignal
that normally prevents the exiting of STING
toward the ERGIC in the absence of stimu-
lation. Interestingly, these STING mutants
were not translocated to the above-
mentioned punctate structures, and they
were also largely resistant to degradation.
While the latter phenomenon could be ex-
plainedby the lack of an additional cGAMP
signal that seems to be required to facili-
tate STING degradation (Konno et al.,
2013), the authors furthermore show that
additional cGAS activation does not
initiate the decay of this type of STINGmu-
tants. Thus, it appears that a special struc-
tural feature of activated, wild-type STINGat the ERGIC is required to allow its exit
from this compartment for subsequent
degradation. In this regard it should be
informative to further dissect the mecha-
nisms that facilitate STING transport
beyond the ERGIC.
Collectively, the data provided by the
new study assign an important role to
the ERGIC in STING signaling, adding
this unique organelle to the ever-growing
list of subcellular compartments that
serve as platforms for the initiation of
anti-microbial signal transduction. Further
dissection of STING trafficking may
inform the design of specific therapeutic
strategies, geared at the inhibition of
STING in the context of sterile inflamma-
tory conditions.REFERENCES
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Dectin-1, a b-glucan receptor, contributes to host anti-fungal defense. In this issue of Cell Host & Microbe,
Tang et al. (2015) show that suppressing Dectin-1 signaling protects mice from experimental colitis by
decreasing anti-microbial peptide production, which allows overgrowth of Lactobacilli and triggers T regu-
latory cell expansion in the gut.Mammalian gastrointestinal (GI) tract is
colonized with diverse commensal
microbial communities consisting of bac-
teria, fungi, and viruses. The host
mucosal immune system has evolved
to tolerate and control this complex
ecosystem while ensuring responses
against invading pathogens. Deficiencies
in genes involved in key innate and adap-
tive immune pathways often lead to
disorders characterized by intestinal
manifestations and loss of microbial di-
versity, or so called dysbiosis. Many of
these pathways play a role in the interac-
tion with bacteria and viruses. Recent
studies have shown that deficiencies ingenes encoding factors involved in anti-
fungal immunity can also contribute to
diseases targeting the mammalian GI
tract (Underhill and Iliev, 2014). The
fungal counterpart (mycobiota) of the
intestinal microbiota has attracted scien-
tific attention as a possible disease
component during these deficiencies.
Among different antifungal receptors,
Dectin-1 has been extensively studied
for its important role in fungal phagocy-
tosis, killing, and cytokine response. Dec-
tin-1 is a transmembrane receptor that
recognizes fungal b-glucan (Taylor et al.,
2007). Mice deficient in Dectin-1 are high-
ly susceptible to invasive fungal diseasedue to decreased ability of phagocytes
to sense, kill, and respond to Candida
(Taylor et al., 2007). This predisposition,
however, is dependent on the fungal
strain suggesting that some fungi are
able to more efficiently mask cell wall
b-glucans and become invisible to Dec-
tin-1. In addition to its role in systemic
protection against fungi, there is sufficient
evidence that Dectin-1 is involved in the
host control of fungi at various body sur-
faces, including the skin (Kashem et al.,
2015), lungs (Werner et al., 2009), vagina
(Carvalho et al., 2012), and the GI tract
(Carvalho et al., 2012; Iliev et al., 2012;
Plantinga et al., 2009) with some, August 12, 2015 ª2015 Elsevier Inc. 139
